643
Views
112
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function

, , , &
Pages 156-164 | Received 18 Jun 2010, Accepted 10 Aug 2010, Published online: 07 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Zhiqian Zhang, Xu Huang, Enlin Wang, Yugang Huang & Rongcun Yang. (2021) Identification and characterization of B220+/B220− subpopulations in murine Gr1+CD11b+ cells during tumorigenesis. OncoImmunology 10:1.
Read now
Li-Chun Lu, Chun-Jung Chang & Chih-Hung Hsu. (2019) Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives. Journal of Hepatocellular Carcinoma 6, pages 71-84.
Read now
Cheng Sun, Jing Xu, Qiang Huang, Mei Huang, Hao Wen, Chuanshan Zhang, Jinyu Wang, Jiaxi Song, Meijuan Zheng, Haoyu Sun, Haiming Wei, Weihua Xiao, Rui Sun & Zhigang Tian. (2017) High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer. OncoImmunology 6:1.
Read now
Alejandro J. Garcia, Marcus Ruscetti, Teresita L. Arenzana, Linh M. Tran, Daniella Bianci-Frias, Elysia Sybert, Saul J. Priceman, Lily Wu, Peter S. Nelson, Stephen T. Smale & Hong Wu. (2014) Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression. Molecular and Cellular Biology 34:11, pages 2017-2028.
Read now

Articles from other publishers (108)

Nikoleta Bizymi, Andreas M. Matthaiou, Irene Mavroudi, Aristea Batsali & Helen A. Papadaki. (2023) Immunomodulatory actions of myeloid-derived suppressor cells in the context of innate immunity. Innate Immunity.
Crossref
Young Hun Chung, Oscar A. Ortega-Rivera, Britney A. Volckaert, Eunkyeong Jung, Zhongchao Zhao & Nicole F. Steinmetz. (2023) Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis. Proceedings of the National Academy of Sciences 120:43.
Crossref
Qianyu Wang, Xiaofei Shen, Gang Chen & Junfeng Du. (2023) How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation. International Journal of Cancer 153:4, pages 709-722.
Crossref
Qianqian Sun, Heng Dai, Siliang Wang, Yuanyuan Chen & Huilian Shi. (2023) Progress in research on the role played by myeloid‐derived suppressor cells in liver diseases. Scandinavian Journal of Immunology.
Crossref
Yaxian Wang, Xinyang Zhong, Xuefeng He, Zijuan Hu, Huixia Huang, Jiayu Chen, Keji Chen, Senlin Zhao, Ping Wei & Dawei Li. (2023) Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, Haikui Yang, Jiamei Dong, Xin He, Yang Yang, Jiahao Guo, Jiawen Cui & Zhiling Zhou. (2023) Impaired function of dendritic cells within the tumor microenvironment. Frontiers in Immunology 14.
Crossref
Shiyue Zhou, Zixuan Zhao, Hao Zhong, Zehao Ren, Yuye Li, Hong Wang & Yuling Qiu. (2023) The role of myeloid-derived suppressor cells in liver cancer. Discover Oncology 14:1.
Crossref
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Vasileios Lekakis, Spyridon Davakis, Maria-Ioanna Christodoulou, Georgios Germanidis & Stamatios Theocharis. (2023) The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?. Cancers 15:10, pages 2795.
Crossref
Junfeng Liu, Raziye Piranlioglu, Fei Ye, Kai Shu, Ting Lei & Hiroshi Nakashima. (2023) Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Györgyi Műzes & Ferenc Sipos. (2023) Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy. Biomedicines 11:4, pages 1130.
Crossref
Boyuan Huang, Jin Zhang, Wenjing Zong, Sisi Chen, Zhitao Zong, Xiaojun Zeng & Hongbo Zhang. (2023) Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies. Frontiers in Immunology 14.
Crossref
Xiaoqiang Gao & Shi Zuo. (2023) Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells. Clinical and Experimental Medicine.
Crossref
Dylan A. Goodin & Hermann B. Frieboes. (2023) Evaluation of innate and adaptive immune system interactions in the tumor microenvironment via a 3D continuum model. Journal of Theoretical Biology 559, pages 111383.
Crossref
Yavuz Emre Parlar, Sefika Nur Ayar, Deniz Cagdas & Yasemin H Balaban. (2023) Liver immunity, autoimmunity, and inborn errors of immunity. World Journal of Hepatology 15:1, pages 52-67.
Crossref
Moumita Basak, Dharmendra Kumar Chaudhary, Ryou-u Takahashi, Yuki Yamamoto, Swasti Tiwari, Hidetoshi Tahara & Anupama Mittal. (2022) Immunocyte Derived Exosomes: Insight into the Potential Chemo-immunotherapeutic Nanocarrier Targeting the Tumor Microenvironment. ACS Biomaterials Science & Engineering 9:1, pages 20-39.
Crossref
Eliana Borgna, Estefanía Prochetto, Juan Cruz Gamba, Iván Marcipar & Gabriel Cabrera. 2023. Myeloid-derived suppressor cells. Myeloid-derived suppressor cells 117 163 .
Qian Li, Jingjing Han, Yonglin Yang & Yu Chen. (2022) PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Frontiers in Immunology 13.
Crossref
Jae-young Lee, Hyun-Jung Sohn, Chang-Hyun Kim, Tai-Gyu Kim & Hyun Soo Lee. (2022) Local and Systemic Injections of Human Cord Blood Myeloid-Derived Suppressor Cells to Prevent Graft Rejection in Corneal Transplantation. Biomedicines 10:12, pages 3223.
Crossref
Zhou Zhou, Yuhao Hu, Yixuan Wu, Qianyi Qi, Jianxin Wang, Lin Chen & Feng Wang. (2022) The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook. Molecular Immunology 151, pages 218-230.
Crossref
Wangkai Liu, Sitao Li, Yushan Li, Wei Shen, Haitian Chen, Xiaoyu Li, Linnuan Cai, Fan Wu, Yumei Liu, Qiong Meng & Xiaoyun Jiang. (2022) Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants. Oxidative Medicine and Cellular Longevity 2022, pages 1-8.
Crossref
Anik Pramanik & Sankar Bhattacharyya. (2022) Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment. Life Sciences 305, pages 120755.
Crossref
Chiel van Geffen, Constantin Heiss, Astrid Deißler & Saeed Kolahian. (2022) Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation. Frontiers in Immunology 13.
Crossref
Daniel Sanghoon Shin, Kevin Park, Edward Garon & Steven Dubinett. (2022) Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Seminars in Oncology 49:3-4, pages 306-318.
Crossref
Muhammad Sajid, Lianxin Liu & Cheng Sun. (2022) The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications. Frontiers in Immunology 13.
Crossref
Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom, Natalia Marek-Trzonkowska & Piotr Trzonkowski. (2022) Autoimmunity and Cancer—Two Sides of the Same Coin. Frontiers in Immunology 13.
Crossref
Carlos Jiménez-Cortegana, Claudia Galassi, Vanessa Klapp, Dmitry I. Gabrilovich & Lorenzo Galluzzi. (2022) Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research 10:5, pages 545-557.
Crossref
Farid Ghorbaninezhad, Zahra Asadzadeh, Javad Masoumi, Ahad Mokhtarzadeh, Tohid Kazemi, Leili Aghebati-Maleki, Siamak Sandoghchian Shotorbani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nima Hemmat, Mohammad Bakhshivand & Behzad Baradaran. (2022) Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside. Life Sciences 297, pages 120466.
Crossref
Haijie Wu, Mingyue Zhong & Yuzhen Wang. 2022. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 1135 1151 .
Jia-Nan Cheng, Yi-Xiao Yuan, Bo Zhu & Qingzhu Jia. (2021) Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression. Frontiers in Cell and Developmental Biology 9.
Crossref
Xueyan Li, Jiahui Zhong, Xue Deng, Xuan Guo, Yantong Lu, Juze Lin, Xuhui Huang & Changjun Wang. (2021) Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy. Frontiers in Immunology 12.
Crossref
Khadijeh Koushki, Maryam Salemi, Seyed Mohammad Miri, Yaser Arjeini, Mohsen Keshavarz & Amir Ghaemi. (2021) Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19. Biomedicine & Pharmacotherapy 144, pages 112346.
Crossref
Zhiguo Ling, Chuan Yang, Jiulin Tan, Ce Dou & Yueqi Chen. (2021) Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases. Cellular and Molecular Life Sciences 78:23, pages 7161-7183.
Crossref
Antero Salminen. (2021) Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions. Journal of Molecular Medicine 99:11, pages 1553-1569.
Crossref
Zengpanpan Ye, Xiaolin Ai, Linjie Zhao, Fan Fei, Ping Wang & Shengtao Zhou. (2021) Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics. Oncogene 40:42, pages 6059-6070.
Crossref
Yuxiang Fan, Yubo Wang, Jian Zhang, Xuechao Dong, Pu Gao, Kai Liu, Chengyuan Ma & Gang Zhao. (2021) Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment. Frontiers in Immunology 12.
Crossref
Ali Asgarzade, Alireza Ziyabakhsh, Vahid Asghariazar & Elham Safarzadeh. (2021) Myeloid-derived suppressor cells: Important communicators in systemic lupus erythematosus pathogenesis and its potential therapeutic significance. Human Immunology 82:10, pages 782-790.
Crossref
Qinxin Liu, Yuchang Wang, Qiang Zheng, Xijie Dong, Zhenxing Xie, Adriana Panayi, Xiangjun Bai & Zhanfei Li. (2021) MicroRNA-150 inhibits myeloid-derived suppressor cells proliferation and function through negative regulation of ARG-1 in sepsis. Life Sciences 278, pages 119626.
Crossref
Houhui Shi, Kai Li, Yanghong Ni, Xiao Liang & Xia Zhao. (2021) Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy. Frontiers in Cell and Developmental Biology 9.
Crossref
Cheng Cui, Penglin Lan & Li Fu. (2021) The role of myeloid‐derived suppressor cells in gastrointestinal cancer. Cancer Communications 41:6, pages 442-471.
Crossref
Amber G. Bozward, Frazer Warricker, Ye H. Oo & Salim I. Khakoo. (2021) Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade. Frontiers in Immunology 12.
Crossref
Senthilnath Lakshmanachetty, Joselyn Cruz-Cruz, Eric Hoffmeyer, Allison P. Cole & Siddhartha S. Mitra. (2021) New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Cells 10:4, pages 893.
Crossref
Ayman J. Oweida, Adam C. Mueller, Miles Piper, Dallin Milner, Benjamin Van Court, Shilpa Bhatia, Andy Phan, Thomas Bickett, Kimberly Jordan, Theresa Proia, Richard Schulick, Wells A. Messersmith, Marco Del Chiaro, Eric Clambey, Michael J. Gough, Jason Williams, Kirk Hansen, Karyn Goodman & Sana D. Karam. (2020) Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunology, Immunotherapy 70:4, pages 989-1000.
Crossref
Suzanne Ostrand-Rosenberg. (2021) Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced Cancer. Annual Review of Cancer Biology 5:1, pages 17-38.
Crossref
Mukaddes Izci, Christy Maksoudian, Bella B. Manshian & Stefaan J. Soenen. (2021) The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. Chemical Reviews 121:3, pages 1746-1803.
Crossref
Maximilian Haist, Henner Stege, Stephan Grabbe & Matthias Bros. (2021) The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment. Cancers 13:2, pages 210.
Crossref
Haijie Wu, Mingyue Zhong & Yuzhen Wang. 2020. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 1 17 .
Ece Tavukcuoglu, Utku Horzum, Hamdullah Yanik, Aysegul Uner, Digdem Yoyen‐Ermis, Safa K. Nural, Busra Aydin, Cenk Sokmensuer, Derya Karakoc, Kerim Bora Yilmaz, Erhan Hamaloglu & Gunes Esendagli. (2020) Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer. European Journal of Immunology 50:12, pages 2067-2074.
Crossref
Natascha Köstlin-Gille & Christian Gille. (2020) Myeloid-Derived Suppressor Cells in Pregnancy and the Neonatal Period. Frontiers in Immunology 11.
Crossref
Li Liu, Qingqing Lin, Jie Peng, Jun Fang, Zhiwu Tan, Hangying Tang, Kayi Kwan, Kenji Nishiura, Jianguo Liang, Hauyee Kwok, Zhenglong Du, Jiaze Sun, Kang Liu, Kwok-Yung Yuen, Hui Wang & Zhiwei Chen. (2020) Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰. EBioMedicine 60, pages 103008.
Crossref
Yufei Wang, Anna Jia, Yujing Bi, Yuexin Wang, Qiuli Yang, Yejin Cao, Yan Li & Guangwei Liu. (2020) Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy. Cancers 12:9, pages 2626.
Crossref
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani & Ammar Daoud. (2020) Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine. Open Biology 10:9.
Crossref
Yuhui Yang, Chunyan Li, Tao Liu, Xiaofang Dai & Alexandr V. Bazhin. (2020) Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Frontiers in Immunology 11.
Crossref
Yajing Mi, Na Guo, Jing Luan, Jianghong Cheng, Zhifang Hu, Pengtao Jiang, Weilin Jin & Xingchun Gao. (2020) The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment. Frontiers in Immunology 11.
Crossref
Yufei Wang, Anna Jia, Yujing Bi, Yuexin Wang & Guangwei Liu. (2020) Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer. Cells 9:4, pages 1011.
Crossref
Shanshan Deng, Michael J. Clowers, Walter V. Velasco, Marco Ramos-Castaneda & Seyed Javad Moghaddam. (2020) Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment. Frontiers in Oncology 9.
Crossref
Shangwei Zhong, Ji-Hak Jeong, Zhikang Chen, Zihua Chen & Jun-Li Luo. (2020) Targeting Tumor Microenvironment by Small-Molecule Inhibitors. Translational Oncology 13:1, pages 57-69.
Crossref
Takahiro Kodama & Tetsuo Takehara. 2020. Liver Immunology. Liver Immunology 505 524 .
Mohammad-Javad Sanaei, Loghman Salimzadeh & Nader Bagheri. (2020) Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer. Journal of Leukocyte Biology 107:1, pages 43-56.
Crossref
Chen Lu, Dawei Rong, Betty Zhang, Wubin Zheng, Xuehao Wang, Ziyi Chen & Weiwei Tang. (2019) Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Molecular Cancer 18:1.
Crossref
Viktor Umansky, Gosse J. Adema, Jaroslaw Baran, Sven Brandau, Jo A. Van Ginderachter, Xiaoying Hu, Jadwiga Jablonska, Slavko Mojsilovic, Helen A. Papadaki, Yago Pico de Coaña, Kim C. M. Santegoets, Juan F. Santibanez, Karine Serre, Yu Si, Isabela Sieminska, Maria Velegraki & Zvi G. Fridlender. (2018) Interactions among myeloid regulatory cells in cancer. Cancer Immunology, Immunotherapy 68:4, pages 645-660.
Crossref
Irene T. Schrijver, Charlotte Théroude & Thierry Roger. (2019) Myeloid-Derived Suppressor Cells in Sepsis. Frontiers in Immunology 10.
Crossref
Wei-Chen Lee, Yu-Chao Wang, Chih-Hsien Cheng, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou & Kun-Ming Chan. (2019) Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma. Scientific Reports 9:1.
Crossref
Seidu A. Richard. (2018) Myeloid-derived Suppressor Cells in Cancer: A Review on the Pathogenesis and Therapeutic Potentials. The Open Cancer Immunology Journal 7:1, pages 16-33.
Crossref
Ketema Abdissa, Andreas Nerlich, Andreas Beineke, Nanthapon Ruangkiattikul, Vinay Pawar, Ulrike Heise, Nina Janze, Christine Falk, Dunja Bruder, Ulrike Schleicher, Christian Bogdan, Siegfried Weiss & Ralph Goethe. (2018) Presence of Infected Gr-1intCD11bhiCD11cint Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in Mycobacterium avium-Infected Mice. Frontiers in Immunology 9.
Crossref
Kanako Shimizu, Tomonori Iyoda, Masahiro Okada, Satoru Yamasaki & Shin-ichiro Fujii. (2018) Immune suppression and reversal of the suppressive tumor microenvironment. International Immunology 30:10, pages 445-455.
Crossref
Andrew Bryant, Borna Mehrad, Todd Brusko, James West & Lyle Moldawer. (2018) Myeloid-Derived Suppressor Cells and Pulmonary Hypertension. International Journal of Molecular Sciences 19:8, pages 2277.
Crossref
Yijun Liu, Guowei Wei, Wesley A. Cheng, Zhenyuan Dong, Han Sun, Vincent Y. Lee, Soung-Chul Cha, D. Lynne Smith, Larry W. Kwak & Hong Qin. (2018) Targeting myeloid-derived suppressor cells for cancer immunotherapy. Cancer Immunology, Immunotherapy 67:8, pages 1181-1195.
Crossref
Jiang Nan, Yan‐Fang Xing, Bo Hu, Jian‐Xin Tang, Hui‐Min Dong, Yu‐Mei He, Dan‐Yun Ruan, Qing‐Jian Ye, Jia‐Rong Cai, Xiao‐Kun Ma, Jie Chen, Xiu‐Rong Cai, Ze‐Xiao Lin, Xiang‐Yuan Wu & Xing Li. (2017) Endoplasmic reticulum stress induced LOX‐1 +  CD 15 + polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinoma . Immunology 154:1, pages 144-155.
Crossref
Silvana Balzan & Valter Lubrano. (2018) LOX-1 receptor: A potential link in atherosclerosis and cancer. Life Sciences 198, pages 79-86.
Crossref
Anca Dorhoi & Nelita Du Plessis. (2018) Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections. Frontiers in Immunology 8.
Crossref
Gyongyi Szabo, Banishree Saha & Aditya Ambade. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 66 76.e5 .
Juan F. Santibanez & Suncica Bjelica. (2017) Transforming Growth Factor-Beta1 and Myeloid-Derived Suppressor Cells Interplay in Cancer. The Open Cancer Immunology Journal 6:1, pages 1-14.
Crossref
Ting-Ting Cai, Shu-Biao Ye, Yi-Na Liu, Jia He, Qiu-Yan Chen, Hai-Qiang Mai, Chuan-Xia Zhang, Jun Cui, Xiao-Shi Zhang, Pierre Busson, Yi-Xin Zeng & Jiang Li. (2017) LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. PLOS Pathogens 13:7, pages e1006503.
Crossref
Haijun Li & Zhengkun Tu. 2017. Biology of Myelomonocytic Cells. Biology of Myelomonocytic Cells.
Xing Li, Yan-Fang Xing, Ai-Hua Lei, Qiang Xiao, Zhi-Huan Lin, Ying-Fen Hong, Xiang-Yuan Wu & Jie Zhou. (2017) Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients. Oncotarget 8:15, pages 24380-24388.
Crossref
Qingmin Gao, Jingwei Jiang, Zhaohui Chu, Hao Lin, Xinli Zhou & Xiaohua Liang. (2017) Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity. Oncology Letters 13:4, pages 2141-2150.
Crossref
Kai Dai, Ling Huang, Ya-bing Huang, Zu-bing Chen, Li-hua Yang & Ying-an Jiang. (2017) 1810011o10 Rik Inhibits the Antitumor Effect of Intratumoral CD8+ T Cells through Suppression of Notch2 Pathway in a Murine Hepatocellular Carcinoma Model. Frontiers in Immunology 8.
Crossref
N. N. Polishchuk & A. M. Kamyshny. (2017) EFFECT BY INTESTINAL MICROBIOM ON THE PROGRESSION OF VIRAL HEPATITIS. Russian Journal of Infection and Immunity 6:4, pages 325-334.
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 121 149 .
Z. Su, P. Ni, C. Zhou & J. Wang. (2016) Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?. Scandinavian Journal of Immunology 84:5, pages 255-261.
Crossref
Hyun-Jeong Ko & Yeon-Jeong Kim. (2016) Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer. Archives of Pharmacal Research 39:11, pages 1597-1608.
Crossref
Athalia Rachel Pyzer, Leandra Cole, Jacalyn Rosenblatt & David E Avigan. (2016) Myeloid-derived suppressor cells as effectors of immune suppression in cancer. International Journal of Cancer 139:9, pages 1915-1926.
Crossref
Yu-Feng Liu, Jian-Yang Wei, Mao-Hua Shi, Hua Jiang & Jie Zhou. (2016) Glucocorticoid Induces Hepatic Steatosis by Inhibiting Activating Transcription Factor 3 (ATF3)/S100A9 Protein Signaling in Granulocytic Myeloid-derived Suppressor Cells. Journal of Biological Chemistry 291:41, pages 21771-21785.
Crossref
Bo-Ra Lee, Bo-Eun Kwon, Eun-Hye Hong, Aeri Shim, Jae-Hyoung Song, Hong-Min Kim, Sun-Young Chang, Yeon-Jeong Kim, Mi-Na Kweon, Je-In Youn & Hyun-Jeong Ko. (2016) Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells. Cancer Letters 381:1, pages 156-164.
Crossref
Zongwen Shuai, Miranda WY Leung, Xiaosong He, Weici Zhang, Guoxiang Yang, Patrick SC Leung & M Eric Gershwin. (2016) Adaptive immunity in the liver. Cellular & Molecular Immunology 13:3, pages 354-368.
Crossref
Xiaoli Pang, Hongxiao Song, Qianqian Zhang, Zhengkun Tu & Junqi Niu. (2016) Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling. Clinical Immunology 164, pages 57-64.
Crossref
Morteza Motallebnezhad, Farhad Jadidi-Niaragh, Elmira Safaie Qamsari, Salman Bagheri, Tohid Gharibi & Mehdi Yousefi. (2015) The immunobiology of myeloid-derived suppressor cells in cancer. Tumor Biology 37:2, pages 1387-1406.
Crossref
Irina Lyadova Vladimirovna, Ekaterina Sosunova, Alexander Nikolaev & Tatiana Nenasheva. (2016) Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation. Journal of Immunology Research 2016, pages 1-17.
Crossref
Chao Zhang, Shuo Wang, Cheng Yang & Ruiming Rong. (2016) The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation. Journal of Immunology Research 2016, pages 1-6.
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 1 29 .
Douglas Marvel & Dmitry I. Gabrilovich. (2015) Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. Journal of Clinical Investigation 125:9, pages 3356-3364.
Crossref
Rohini R. Nair, Pratima Sinha, Anuradha Khanna & Kiran Singh. (2015) Reduced Myeloid-derived Suppressor Cells in the Blood and Endometrium is Associated with Early Miscarriage. American Journal of Reproductive Immunology 73:6, pages 479-486.
Crossref
Rebekah M Weston & Cordula M Stover. (2015) Myeloid derived suppressor cells in breast cancer: A novel therapeutic target?. World Journal of Immunology 6:3, pages 119.
Crossref
Yeon-Jeong KimSun-Young ChangHyun-Jeong Ko. (2015) Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease. Intestinal Research 13:2, pages 105.
Crossref
Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera & Michele Malaguarnera. (2015) The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies. BioMed Research International 2015, pages 1-12.
Crossref
Shasha Song, Pingfan Yuan, Peipei Li, Huaxun Wu, Jingtao Lu & Wei Wei. (2014) Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma. International Immunopharmacology 22:2, pages 392-399.
Crossref
Wenxiu Zhao, Lei Zhang, Yaping Xu, Zhengqi Zhang, Guangli Ren, Kai Tang, Penghao Kuang, Bixing Zhao, Zhenyu Yin & Xiaomin Wang. (2014) Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model. Laboratory Investigation 94:2, pages 182-191.
Crossref
Celeste Goh, Sowmya Narayanan & Young S. Hahn. (2013) Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?. Immunological Reviews 255:1, pages 210-221.
Crossref
Beicheng Sun & Michael Karin. (2013) Inflammation and liver tumorigenesis. Frontiers of Medicine 7:2, pages 242-254.
Crossref
Yan-Li Zhang, Bin Luan, Xiu-Fang Wang, Jun-Ying Qiao, Li Song, Rui-Rui Lei, Wei-Xia Gao & Ying Liu. (2013) Peripheral Blood MDSCs, IL-10 and IL-12 in Children with Asthma and Their Importance in Asthma Development. PLoS ONE 8:5, pages e63775.
Crossref
Suzanne Ostrand-Rosenberg & Pratima Sinha. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment 177 196 .
Chi Ma, Tamar Kapanadze, Jaba Gamrekelashvili, Michael P Manns, Firouzeh Korangy & Tim F Greten. (2012) Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. Journal of Leukocyte Biology 92:6, pages 1199-1206.
Crossref
Suzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W. Beury & Virginia K. Clements. (2012) Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Seminars in Cancer Biology 22:4, pages 275-281.
Crossref
Antonio Sica, Chiara Porta, Sara Morlacchi, Stefania Banfi, Laura Strauss, Monica Rimoldi, Maria Grazia Totaro & Elena Riboldi. (2011) Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs). Cancer Microenvironment 5:2, pages 133-149.
Crossref
Dmitry I. Gabrilovich, Suzanne Ostrand-Rosenberg & Vincenzo Bronte. (2012) Coordinated regulation of myeloid cells by tumours. Nature Reviews Immunology 12:4, pages 253-268.
Crossref
So-Youn Min, Yuyang Fu, Jack Hutcheson, Tianfu Wu, Elhaum Khobahy, Jiankun Zhu, Kamala Vanarsa, Yong Du, Min-Jung Park, Hyun-Sil Park, Ramesh Saxena, Ho-Youn Kim & Chandra Mohan. (2012) Peritoneal catheter implantation elicits IL-10-producing immune-suppressor macrophages through a MyD88-dependent pathway. Clinical Immunology 143:1, pages 59-72.
Crossref
Travis E. Grotz, Aaron S. Mansfield, James W. Jakub & Svetomir N. Markovic. (2012) Regional lymphatic immunity in melanoma. Melanoma Research 22:1, pages 9-18.
Crossref
Monireh Torabi-Rahvar, Mahmood Bozorgmehr, Mahmood Jeddi-Tehrani & Amir Hassan Zarnani. (2011) Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat. Drug Discovery Today 16:15-16, pages 733-740.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.